First Time Loading...

Sino Biological Inc
SZSE:301047

Watchlist Manager
Sino Biological Inc Logo
Sino Biological Inc
SZSE:301047
Watchlist
Price: 75.86 CNY -1.24%
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one Sino Biological Inc stock under the Base Case scenario is 46.65 CNY. Compared to the current market price of 75.86 CNY, Sino Biological Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
46.65 CNY
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

15.3
P/S
P/S
Price to Sales
15.3
vs History
80
vs Industry
38
Median 3Y
20.4
Median 5Y
20.4
Industry
8.2
Forward
14.4
More Details
44.5
P/E
P/E
Price to Earnings
44.5
vs History
28
vs Industry
4
Median 3Y
35.9
Median 5Y
35.9
Industry
27.4
Forward
31.6
More Details
32
P/OCF
P/OCF
Price to OCF
32
vs History
65
vs Industry
5
Median 3Y
36
Median 5Y
36
Industry
24.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
22.5
Median 5Y
22.5
Industry
23
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
82
vs Industry
53
Median 3Y
2
Median 5Y
2
Industry
2.6
More Details
8
EV/S
EV/S
Enterprise Value to Sales
8
vs History
82
vs Industry
42
Median 3Y
12.1
Median 5Y
12.1
Industry
7.5
Forward
7.5
More Details
10.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.2
vs History
82
vs Industry
39
Median 3Y
14.3
Median 5Y
14.3
Industry
9.3
More Details
44.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
44.5
vs History
11
vs Industry
3
Median 3Y
31.5
Median 5Y
31.5
Industry
4.3
Forward
14.9
More Details
44.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
44.5
vs History
11
vs Industry
3
Median 3Y
31.5
Median 5Y
31.5
Industry
4.2
Forward
32.3
More Details
16.9
EV/OCF
EV/OCF
Enterprise Value to OCF
16.9
vs History
77
vs Industry
9
Median 3Y
23.9
Median 5Y
23.9
Industry
5.9
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
18.2
Median 5Y
18.2
Industry
3.3
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
82
vs Industry
43
Median 3Y
10.5
Median 5Y
10.5
Industry
4.9
More Details

Multiples Across Competitors

Competitors Multiples
Sino Biological Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Sino Biological Inc
SZSE:301047
9.9B CNY 15.3 44.5 44.5 44.5
US
Abbvie Inc
NYSE:ABBV
285.4B USD 5.3 59.2 12.9 19.6
US
Amgen Inc
NASDAQ:AMGN
167B USD 5.7 44.4 18.7 30.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
110.4B USD 11.2 30.5 24.6 25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
108.5B USD 8.3 28.1 22.8 25.2
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36.2 21.9 27.1
US
Gilead Sciences Inc
NASDAQ:GILD
84.3B USD 3.1 174.2 7 9.2
US
Moderna Inc
NASDAQ:MRNA
49.1B USD 9.5 -8.2 -9 -8
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33B USD 3.4 28.3 14.4 18
KR
Celltrion Inc
KRX:068270
39.6T KRW 18.2 73.8 45.2 62.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.